Search research articles
Contact Us
Filters
Showing results (261-270 of 358) with videos related to
Page
of 36
Sort By:
The American Journal of Surgical Pathology
|
September 10, 2009
Tenascin-X is a novel diagnostic marker of malignant mesothelioma
Yuan Yuan, Dag André Nymoen, Helene Tuft Stavnes, et al.
Journal for Immunotherapy of Cancer
|
October 29, 2021
Peptide vaccine targeting mutated <i>GNAS</i>: a potential novel treatment for pseudomyxoma peritonei
Kjersti Flatmark, Annette Torgunrud, Karianne G Fleten, et al.
Human Pathology
|
November 2, 2012
Aurora B expression in metastatic effusions from advanced-stage ovarian serous carcinoma is predictive of intrinsic chemotherapy resistance
Thea Eline Hetland, Dag Andre Nymoen, Arild Holth, et al.
Cancer
|
May 13, 2004
Granulin-epithelin precursor is a novel prognostic marker in epithelial ovarian carcinoma
Ben Davidson, Emilyn Alejandro, Vivi Ann Flørenes, et al.
BMC Cancer
|
September 13, 2017
Involvement of DPP9 in gene fusions in serous ovarian carcinoma
Marianne Lislerud Smebye, Antonio Agostini, Bjarne Johannessen, et al.
Human Pathology
|
May 21, 2009
Expression of the folate receptor genes FOLR1 and FOLR3 differentiates ovarian carcinoma from breast carcinoma and malignant mesothelioma in serous effusions
Yuan Yuan, Dag André Nymoen, Hiep Phuc Dong, et al.
Human Pathology
|
October 24, 2007
Expression and clinical role of DJ-1, a negative regulator of PTEN, in ovarian carcinoma
Ben Davidson, Rivka Hadar, Anat Schlossberg, et al.
Clinical & Experimental Metastasis
|
December 13, 2003
Expression of the 67 kDa laminin receptor and the alpha6 integrin subunit in serous ovarian carcinoma
Vered Givant-Horwitz, Ben Davidson, Gregg van de Putte, et al.
Human Pathology
|
December 3, 2014
The clinical role of epithelial-mesenchymal transition and stem cell markers in advanced-stage ovarian serous carcinoma effusions
Ben Davidson, Arild Holth, Ellen Hellesylt, et al.
Gynecologic Oncology
|
December 14, 2004
HLA-G expression in effusions is a possible marker of tumor susceptibility to chemotherapy in ovarian carcinoma
Ben Davidson, Mari Bukholt Elstrand, Michael T McMaster, et al.
Page
of 36
Search research articles
Search
Showing results (261-270 of 358) with videos related to
Sort By:
Page
of 36
The American Journal of Surgical Pathology
|
September 10, 2009
Tenascin-X is a novel diagnostic marker of malignant mesothelioma
Yuan Yuan, Dag André Nymoen, Helene Tuft Stavnes, et al.
Journal for Immunotherapy of Cancer
|
October 29, 2021
Peptide vaccine targeting mutated <i>GNAS</i>: a potential novel treatment for pseudomyxoma peritonei
Kjersti Flatmark, Annette Torgunrud, Karianne G Fleten, et al.
Human Pathology
|
November 2, 2012
Aurora B expression in metastatic effusions from advanced-stage ovarian serous carcinoma is predictive of intrinsic chemotherapy resistance
Thea Eline Hetland, Dag Andre Nymoen, Arild Holth, et al.
Cancer
|
May 13, 2004
Granulin-epithelin precursor is a novel prognostic marker in epithelial ovarian carcinoma
Ben Davidson, Emilyn Alejandro, Vivi Ann Flørenes, et al.
BMC Cancer
|
September 13, 2017
Involvement of DPP9 in gene fusions in serous ovarian carcinoma
Marianne Lislerud Smebye, Antonio Agostini, Bjarne Johannessen, et al.
Human Pathology
|
May 21, 2009
Expression of the folate receptor genes FOLR1 and FOLR3 differentiates ovarian carcinoma from breast carcinoma and malignant mesothelioma in serous effusions
Yuan Yuan, Dag André Nymoen, Hiep Phuc Dong, et al.
Human Pathology
|
October 24, 2007
Expression and clinical role of DJ-1, a negative regulator of PTEN, in ovarian carcinoma
Ben Davidson, Rivka Hadar, Anat Schlossberg, et al.
Clinical & Experimental Metastasis
|
December 13, 2003
Expression of the 67 kDa laminin receptor and the alpha6 integrin subunit in serous ovarian carcinoma
Vered Givant-Horwitz, Ben Davidson, Gregg van de Putte, et al.
Human Pathology
|
December 3, 2014
The clinical role of epithelial-mesenchymal transition and stem cell markers in advanced-stage ovarian serous carcinoma effusions
Ben Davidson, Arild Holth, Ellen Hellesylt, et al.
Gynecologic Oncology
|
December 14, 2004
HLA-G expression in effusions is a possible marker of tumor susceptibility to chemotherapy in ovarian carcinoma
Ben Davidson, Mari Bukholt Elstrand, Michael T McMaster, et al.
Page
of 36